Berkshire Hathaway to Buy OxyChem from Occidental for $9.7B in All-cash Deal
Occidental announced the $9.7 billion sale of its chemical unit OxyChem to Berkshire Hathaway, potentially Warren Buffett’s final major deal. The move follows Occidental’s $12 billion CrownRock acquisition and is aimed at cutting debt. Cravath advised Occidental, while Berkshire Hathaway was advised by Kirkland & Ellis.
